EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis

Luke D Tyson iD, Stephen Atkinson, Benjamin H Mullish iD, Alexandros Pechlivanis, Michael Allison, Andrew Austin, Katie Chappell, Stuart J Forbes, Ewan H Forrest, Alastair M Kilpatrick, Tong Liu, Laura Martinez-Gili und 11 weitere

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1658-1672

DOI: 10.1111/apt.70616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 23.03.2026. Verfasst von Luke D Tyson und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Bile Acids and Salts, Hepatitis, Alcoholic, Liver Cirrhosis, Alcoholic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, NIHR Imperial Biomedical Research Centre, Health Technology Assessment Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alcohol‐related hepatitis (AH) is characterised by acute cholestasis and liver dysfunction in patients consuming alcohol.

Aims

To define the bile acid (BA) profile in AH compared to decompensated alcohol‐related cirrhosis (DC) and healthy controls (HC).

Methods

Serum and faecal BAs were measured by UHPLC–MS; FGF19 by ELISA; RNA‐sequencing data obtained from liver biopsies; serum cytokines and growth factors quantified by multiplex immunoassay. Hepatocyte growth factor (HGF) was applied to primary human hepatocytes (PHH) and BA transporter expression was assessed by RT‐qPCR.

Results

In two cohorts (Cohort 1: 164 AH, 63 DC, 36 HC; Cohort 2: 94 AH, 175 DC, 72 HC), total serum BAs were highest in AH (median concentration 186.0 μM vs. 64.5 DC vs. 5.0 HC), driven by elevated conjugated primary BAs (182.0 μM vs. 54.0 vs. 2.2). Unconjugated primary BAs were highest in DC. Serum BAs distinguished AH from DC (Cohort 1 AUROC 0.964; Cohort 2 0.922; p < 0.001). Faecal BAs were reduced in AH (0.47 mg/g vs. 1.11 DC vs. 2.64 HC); serum FGF19 elevated (5835 pg/mL AH vs. 865 jaundiced DC [bilirubin > 80 μmol/L]). Serum conjugated BAs correlated negatively with NTCP expression ( n = 25, Spearman's rho −0.432, p = 0.031). CYP7A1 was below the limit of detection. HGF was elevated in AH (7899 pg/mL vs. 2607 DC, p < 0.001). HGF treatment reduced PHH BSEP expression.

Conclusion

Serum conjugated primary BAs accumulate in AH. Elevated HGF may detrimentally affect the hepatoprotective adaptive reduction in NTCP/increase in BSEP seen in cholestasis, contributing to the AH BA profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsHepatitis, AlcoholicLiver Cirrhosis, AlcoholicHumansMaleFemaleMiddle AgedHepatocyte Growth FactorHepatocytesFibroblast Growth FactorsAdultFecesCase-Control StudiesAged

Stichwörter der Autor:innen

alcohol‐associated hepatitisalcohol‐related hepatitisbile acidsfibroblast growth factor 19hepatocyte growth factor

Substanzen

Bile Acids and SaltsHepatocyte Growth FactorFibroblast Growth FactorsFGF19 protein, human

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Imperial College Healthcare NHS Trust, St Mary's Hospital, The Liver Unit, London, UK.
  • GSK, Brentford, UK.
  • Cambridge NIHR Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK.
  • Department of Hepatology, Royal Derby Hospital, Derby, UK.
  • Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Luke D Tyson, Benjamin H Mullish, Mark J W McPhail, Nikhil Vergis

Förderung

  • National Institute for Health and Care Research
  • NIHR Imperial Biomedical Research Centre
  • Health Technology Assessment Programme
  • Imperial College Healthcare NHS Trust
  • Imperial College London
  • Medical Research Council

Zitieren

APA

Tyson, L. D., Atkinson, S., Mullish, B. H., Pechlivanis, A., Allison, M., Austin, A., Chappell, K., Forbes, S. J., Forrest, E. H., Kilpatrick, A. M., Liu, T., Martinez-Gili, L., Masson, S., McPhail, M. J. W., Nunes, J., Richardson, P., Rodrigo-Torres, D., Ryder, S. D., Wright, M., …, & Thursz, M. R. (2026). Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis. Alimentary Pharmacology & Therapeutics, 63(12), 1658-1672. https://doi.org/10.1111/apt.70616

Vancouver

Tyson LD, Atkinson S, Mullish BH, Pechlivanis A, Allison M, Austin A, et al. Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis. Alimentary Pharmacology & Therapeutics. 2026;63(12):1658-1672. doi:10.1111/apt.70616

BibTeX
@article{Tyson2026,
  author = {Tyson, Luke D and Atkinson, Stephen and Mullish, Benjamin H and Pechlivanis, Alexandros and Allison, Michael and Austin, Andrew and Chappell, Katie and Forbes, Stuart J and Forrest, Ewan H and Kilpatrick, Alastair M and Liu, Tong and Martinez-Gili, Laura and Masson, Steven and McPhail, Mark J W and Nunes, Joao and Richardson, Paul and Rodrigo-Torres, Daniel and Ryder, Stephen D and Wright, Mark and Patel, Vishal C and Vergis, Nikhil and Holmes, Elaine and Thursz, Mark R},
  title = {Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {12},
  pages = {1658--1672},
  doi = {10.1111/apt.70616}
}
Kostenlos starten →